A double-blind randomized clinical study of the use of Hexabrix in pediatric angiocardiography.
A double-blind clinical study of 50 children undergoing cardiac catheterization was performed to evaluate Hexabrix and Renografin-76 in pediatric angiocardiography. The contrast agents were randomly assigned. There was no statistical difference in image quality between Hexabrix and Renografin-76 at similar iodine concentrations and no subjective difference in radio-opacity or overall angiographic quality. Little or no discomfort was experienced with Hexabrix whereas with Renografin-76, there was more pain. Hexabrix may be advantageous for cardiovascular diagnosis since motion artifact due to pain can adversely affect angiographic detail.